Project Search Results


Research Categorization


Project Details


Contact Researcher and Awardee Organization


Funding Organization

Displaying 1 - 10 of 12 Projects
Project # Contact PI Funding Organization Fiscal Year
A Placebo Controlled, Randomized Double-blind Parallel Group 12-month Trial of Fasudil for the Treatment of Mild Cognitive Impairment Due to Alzheimer's disease, nested within a Multi-Arm Phase 2 Clinical Trial Platform
ADDF-13 Ballard, Clive Alzheimer's Drug Discovery Foundation 2020
Delivering novel neuro-retinal biomarkers for the early diagnosis of Alzheimer’s disease
GDAPB-201808-2016196 MacGillivray, Tom Alzheimer's Drug Discovery Foundation 2019
Evaluating the effects of the novel GLP-I analogue, liraglutide, in patients with Alzherimer's disease (ELAD Study) - Open Label Extension
GC-2013910 Edison, Paul Alzheimer's Drug Discovery Foundation 2017
Quantification of vascular disease burden to stratify dementia for diagnosis and care managemnt
EUJPND-Innovate UK-Royle-2004 Royle, Natalie Innovate UK 2016
A Digital Brain Health Platform for improving dementia outcomes
EUJPND-Innovate UK-Royle-2005 Royle, Natalie Innovate UK 2016
Imaging the Retina for Early Alzheimer Diagnosis (I-READ)
EUJPND-STW-de Boer-1759 de Boer, Johannes Technology Foundation 2016
Etanercept in Alzheimer's Disease: a randomised, placebo controlled, double-blind phase 2 trial
GH-2012563 HOLMES, CLIVE Alzheimer's Drug Discovery Foundation 2015
Repurposing the PDE5 inhibitor tadalafil for vascular cognitive impairment. A test of concept in older people
20140901-Hainsworth-2014 Hainsworth, Atticus Alzheimer's Drug Discovery Foundation 2014
Novel GLP-1 and GIP dual receptor agonist peptides show neuroprotective effects
222-Holscher-2014 Holscher, Christian Alzheimer's Drug Discovery Foundation 2014
Repurposed drugs targeting the unfolded protein response to prevent neurodegeneration in dementia
223-Mallucci-2014 Mallucci, Giovanna Alzheimer's Drug Discovery Foundation 2014